AzTrials
AzTrials

DrowningPOSEIDONNCT04250532

Pulse Oximetry in Healthy SubjEcts ImmergeD in OceaN.

An observational study of Drowning, run by University Hospital, Bordeaux at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Drowning is the 3rd leading cause of accidental death in the world. One of the tools used by lifeguards to help ER assess gravity, is pulse oximetry. Its measure is variable even in optimal condition and its accuracy can be altered by factors specific to the patient and by environmental factors. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Drowning
What is being tested?
Drowning
How many people
31 participants
Where
1 siteFrance
Study dates
26 Jun 2020to 15 Jul 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Lifeguards working on the Girondine Atlantic coast

Who may be able to join

  • Lifeguard working on the Girondine Atlantic coast
  • up to 18 years old,
  • no smoker,
  • No chronic pathology.

Who cannot join

  • Chronic cardiac pathology,
  • Chronic respiratory pathology,
  • Acrosyndrome,
  • Smoker.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hopital Pellegrin

    Bordeaux, 33000

Other trials in France

About this study

Drowning is the 3rd leading cause of accidental death in the world. One of the tools used by lifeguards to help ER assess gravity, is pulse oximetry. Its measure is variable even in optimal condition and its accuracy can be altered by factors specific to the patient and by environmental factors. The conditions gathered during a drowning rescue are thus propitious to a misleading evaluation. Assessing its reliability and looking for influencing factors of the measure of pulse oximetry could help for pre-hospital care management.

Read the detailed description

The research focuses on the measurement of pulse oximetry among lifeguard on the Atlantic coast of Gironde, France, before and after their daily training, using a standardized measurement protocol.

The follow-up will be done during the beach monitoring period during the summer of 2020. A total of 3 months of measurement collection is expected.

Conditions
Drowning
Being tested
Drowning
Medical subject headings
Drowning

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DrowningOther

    Measurement of pulse oximetry, after lifeguard immersion during their morning training

Study groups in NCT04250532
Study groupRoleWhat they receive
LifeguardLifeguards who work on the Atlantic coast of Gironde France.
Receives: Other: Drowning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of abnormal pulse oximetry measure

    Quantify the number of subjects, whose pulse oximetry is measured as abnormal (superior to 94%) after immersion for 15 min in the ocean, in real condition.

    Measured: 3 months after inclusion day

Secondary outcomes (2)
  1. Variation of pulse oximetry according to individuals factors

    Measures of immersion time, BMI before / after immersion.

    Measured: 3 months after inclusion day

  2. Variation of pulse oximetry according to environnementals factors

    Measures of air, water temperatures, felt air temperature, wet thermometer temperature, wind speed before / after immersion.

    Measured: 3 months after inclusion day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2020
  2. Study start26 Jun 2020
  3. Primary completion15 Jul 2020
  4. Study completion15 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04250532
Sponsor's protocol ID
CHUBX 2019/48
Acronym
POSEIDON
Status last verified
Jun 2021
First submitted
29 Jan 2020
Last updated
7 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Drowning, run by University Hospital, Bordeaux at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of abnormal pulse oximetry measure (time frame: 3 months after inclusion day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in